For instance, the co-expression of CD40L with GM-CSF in bystander cells and with toll-like receptor 4 (TLR4)/CD70 or TLR4/CD70/tumor antigen in autologous DCs was employed for the treatment of advanced lung adenocarcinoma and advanced melanoma. Here, TLR4 is linked to lung adenocarcinoma.